ELISA 诊断测试市场基于(关键地区、市场参与者、规模和份额)- 到 2030 年的预测

  • Report Code : TIPRE00030120
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 199
Buy Now

【研究报告】ELISA诊断检测市场规模预计将从2022年的12.8549亿美元增长到2030年的22.7123亿美元;预计 2022 年至 2030 年复合年增长率为 7.37%。
分析师观点
ELISA 诊断测试市场分析解释了动物传染病增加和人类感染发病率增加等市场驱动因素。此外,基于 ELISA 的程序的进步预计将在 2022 年至 2030 年期间引入市场新趋势。根据采用情况,ELISA 诊断测试市场分为人类和兽医市场。 2022 年,人类细分市场占据了更大的市场份额,预计 2022 年至 2030 年期间复合年增长率将更高。根据测试类型,市场分为夹心 ELISA、间接 ELISA、竞争性 ELISA 以及多重便携式 ELISA。间接 ELISA 细分市场在 2022 年占据最大的市场份额,预计 2020-2030 年复合年增长率最高。按应用划分,市场分为自身免疫性疾病、传染病、癌症诊断、蛋白质定量等。传染病细分市场在 2022 年占据最大市场份额,预计在预测期内将实现最高的复合年增长率。按最终用户划分,ELISA 市场分为医院和诊断中心、制药和生物技术公司、兽医医院和诊断实验室等。医院和诊断中心细分市场在 2022 年占据最大的市场份额,预计在预测期内将实现市场上最高的复合年增长率。
酶联免疫吸附测定 (ELISA) 测试可检测和测量患者血液中的抗体。该测试可用于确定患者是否具有与某些传染病相关的抗体。 ELISA 测试用于诊断引起 HIV 的艾滋病、莱姆病、恶性贫血、轮状病毒和其他疾病。
市场洞察
动物传染病的增加推动 ELISA 诊断测试市场增长
据中心称根据疾病控制与预防 (CDC) 报告,仅在美国,与动物或环境相关的肠道疾病就导致 450,000 例病例、5,000 例住院病例和 76 例死亡。这些疾病是在人类接触动物粪便或体液时观察到的,通过动物接触传播的病原体可能对人类造成危险。此外,世界动物卫生组织发布的一份报告显示,60%的人类感染是与动物有关的疾病。报告还提到,75%的新发动物疾病可以传播给人类,每年有五种动物新发疾病。根据世界卫生组织的报告,全世界每年约有 55,000 起医疗索赔与狂犬病感染有关,其中主要是因被感染的狗咬伤而导致的儿童。此外,《动物健康》报告显示,汉坦病毒、淋巴细胞、脉络膜脑膜炎病毒(LCMV)、鼠疫、沙门氏菌、鼠咬热和兔热病等六种动物相关疾病在12年内造成了价值800亿美元的经济损失。在六种疾病中,仅一种与动物相关的疾病“口蹄疫”每年就给全球农民带来高达 210 亿美元的损失。此外,澳大利亚政府估计,口蹄疫的爆发在 10 年内给农民造成了 509.8 亿美元的直接损失。
奶牛中存在的持续性淋巴细胞增多症 (PL) 可能会在怀孕期间感染犊牛。奶牛的产奶量可能会严重下降,并可能感染周围的其他动物。在这种情况下,酶联免疫吸附测定 (ELISA) 测试最适合测试 PL 疾病阳性的受感染奶牛,因为它可以揭示正确的淋巴细胞计数临床测试结果。此外,据兽医报告,该测试对于感染 55 天的动物的敏感性为 95%。因此,兽医通常建议8个月及以上的动物进行ELISA检测。因此,动物相关疾病发病率的上升推动了对 ELISA 测试的需求。
市场机会
创新产品的推出将为预测期内 ELISA 诊断测试市场提供利润丰厚的机会
ELISA 是最受欢迎的免疫测定之一由于其具有灵活性、灵敏度和易于使用等各种优点,因此可以进行测试。此外,ELISA 检测试剂盒的低成本以及与高通量检测相关的多方面适用性使其成为满足各种研究和 IVD 要求的理想解决方案。凭借低成本的适用性,检测试剂盒的产品创新增强了对人类和动物研究的需求。此外,制造商还专注于利用内部设施开发 ELISA 检测试剂盒。
Innovative Research 公司销售各种 ELISA 试剂盒,在鉴定凝血剂、物种和抗体方面具有广泛的选择性。 “Human Factor IX Kit”就是 Innovative Research 生产的一个这样的例子。人凝血因子 IX 抗原测定旨在定量测定人血浆中总因子 IX 抗原。该试剂盒建议仅用于研究目的,试剂最多可用于 96 项临床测试。
此外,制造商在 COVID-19 大流行期间推出了用于 ELISA 测试的创新产品,加速了 ELISA 测试的采用
制造商在 COVID-19 大流行期间推出 SARS-CoV-2 产品
Sr.编号
制造商
ELISA 试剂盒名称
1
Abbott
PANBIO SARS-CoV-2 IgG ELISA
2
Bio-Techne
SARS-CoV-2 变体抑制剂筛选试剂盒
3
Cellex, Inc.
qSARS-CoV-2 IgG/IgM 快速检测
4
DiaSorin SpA
LIAISON SARS-CoV-2 S1/S2 IgG< br>5
罗氏诊断
Elecsys Anti-SARS-CoV-2
来源:The Insight Partners Analysis
2022 年 12 月,Pictor Limited 宣布推出“PictArray SARS-CoV- 2 抗体测试”,这已经证明了针对患者和医生的真正临床实用性。新产品可检测与 COVID-19 病毒相关的感染,产生的临床结果可帮助患者和医生治疗和管理 SARS-CoV-2 感染。制造商推出的创新 ELISA 检测试剂盒有望以低成本和多方面的应用为诊断与不同类型物种相关的各种感染提供有效的临床结果。因此,从长远来看,创新产品的推出将为制造商提供利润丰厚的机会。
战略见解
报告细分和范围
基于采用的见解
根据采用,ELISA 诊断测试市场分为人类和兽医。到 2022 年,人类细分市场将占据更大的市场份额,预计在预测期内复合年增长率将达到 7.88%。传染病是由细菌、寄生虫、病毒、真菌和其他病原体等传染原引起的。随着环境变化的加剧和卫生条件的恶化,人类感染病例不断增加,全球范围内不断出现新的疾病。 2020 年 1 月,世界卫生组织 (WHO) 宣布新冠肺炎 (COVID-19) 疫情为国际关注的突发公共卫生事件 (PHEIC),初步估计总人数至少为 300 万人,意味着因新冠肺炎死亡人数增加 120 万人。 2020 年全球将达到 19 个。同样,根据世界卫生组织的数据,结核病 (TB) 是全球第 13 大死亡原因,也是仅次于 COVID-19 的第二大传染病。据同一来源称,2021 年,全球有 1,060 万人感染结核病,共有 160 万人死于结核病,其中包括 187,000 名艾滋病毒感染者。
此外,肝炎是一种由 5 种主要甲型肝炎病毒株引起的病毒感染、B、C、D 和 E,是全世界的主要疾病威胁。据世界卫生组织称,全球约有 5800 万人患有慢性丙型肝炎病毒感染,每年新增约 150 万人感染。艾滋病毒/艾滋病、流感、肺结核和许多性传播疾病等传染病需要早期诊断,以便进行疾病管理和控制。血清学检测(例如ELISA检测)可以检测血液、血浆、尿液和粪便样本等生物样本中的病毒和细菌抗原和抗体,以帮助在早期诊断这些疾病。因此,这些传染病在人群中的发病率正在推动全球 ELISA 诊断测试市场在人类领域的增长。
基于测试类型的见解
根据测试类型,全球 ELISA 诊断测试市场细分为夹心 ELISA、间接 ELISA、竞争 ELISA 以及多重便携式 ELISA。间接 ELISA 细分市场在 2022 年占据最大的市场份额,预计在预测期内复合年增长率最高为 8.58%。间接 ELISA 技术广泛用于通过计算样品中存在的抗体量来确定免疫反应的结果。这是一种两步检测技术,涉及使用与目标抗原特异性结合的一抗。然后使用标记的二抗通过与其宿主物种结合来检测一抗。该方法可以通过用血清代替一抗来检测血清样品中的特异性抗体。根据Frontiers 2023年发表的一篇文章,提出了一项使用间接ELISA方法和针对非洲猪瘟病毒(ASFV)pK205R的单克隆抗体的研究。该研究揭示了有效的检测和潜在的应用可能性,使其非常适合非洲猪瘟疫苗研究和流行病学监测。因此,由于间接 ELISA 测试未来潜在的进步和应用,预计 ELISA 诊断测试市场将在 2022 年至 2030 年期间显着增长。
ELISA 诊断测试市场,按采用情况 – 2022 年和 2030 年
区域分析< br>北美 ELISA 诊断测试市场分为美国、加拿大和墨西哥。该地区的市场增长归因于人类传染病的增加和 ELISA 诊断试剂盒的技术进步。根据美国疾病控制与预防中心 (CDC) 2023 年报告,与动物接触有关的人类传染病发病率有所上升。
以下是动物与人之间传播的人畜共患疾病爆发列表.
美国人畜共患细菌病原学
属疾病
疾病
病原体
结构
布鲁氏菌
布鲁氏菌病
细菌
革兰氏球杆菌
沙门氏菌< br>弯曲杆菌病
细菌
革兰氏阴性杆菌
志贺氏菌
志贺氏菌
细菌
革兰氏阴性杆菌
询问钩端螺旋体
引起菌血症的脓毒症
细菌
>革兰氏螺旋体
复发疏螺旋体
菌血症
细菌
革兰氏螺旋体
螺菌
螺旋菌
细菌
革兰氏
土拉弗朗西斯菌
>败血症
细菌
革兰氏球菌
炭疽杆菌
炭疽病
细菌
革兰氏+ve 杆状
来源:Insight Partners 分析
The ClinMed International图书馆 2017 年报告显示,“肠贾第鞭毛虫”是美国最常见的肠道寄生虫感染。而且,在该国,12岁以上人口中有22.5%感染“弓形虫”。此外,近二十年来,美国人畜共患病发病率不断上升,成为美国人口传染病病例上升的重要原因。此外,CDC 2023报告显示,2022年1月美国禽流感(AI)发病率呈上升趋势。CDC报告称,美国有59,031,321只禽类受到AI影响。因此,为了控制美国的禽流感感染,提供了商业 ELISA 检测试剂盒来确认任何阳性结果。因此,由于人畜共患疾病病例数高,人类传染病发病率不断上升,促进了 ELISA 诊断测试在美国的采用。
该报告介绍了全球 ELISA 诊断测试市场的领先参与者。 Bio-Rad Laboratories Inc、Idex Laboratories Inc、F. Hoffmann-La Roche Ltd、Thermo Fisher Scientific Inc、Abbott Laboratories、Danaher Corp、Innovative Diagnostics SAS、Pictor Ltd、DiaSorin SpA、Elabscience Biotechnology Inc 和 Bio-Techne Corp 是市场参与者很少。
2022 年 10 月,罗氏宣布发布下一代 SARS-CoV-2 快速抗原检测产品组合(“2.0”),用于在具有 CE 标志的国家进行自我测试和专业用途。新的快速测试组合预计将在接下来的几周内分发。该测试包括 SARS-CoV-2 快速抗原测试 2.0、供专业用途的 SARS-CoV-2 快速抗原测试 2.0 鼻腔和供自我测试的 SARS-CoV-2 抗原自检鼻腔。 2020年,Bio-Techne Corp推出了新一代ELISA试剂盒。 Bio-Techne Corp 宣布推出 Quantikine 和 QuicKitTM ELISA 产品线。这一新产品线增强了上一代 Quantikine ELISA 试剂盒的功能,使研究人员能够在不牺牲质量的情况下延长工作时间。这些检测方法可在 90 分钟内准确定量血清、血浆和细胞上清液中的蛋白质。公司简介
Bio-Rad Laboratories Inc Idexx Laboratories Inc F. Hoffmann-La Roche Ltd Thermo Fisher Scientific Inc Abbott Laboratories Danaher Corp Innovative Diagnostics SAS Pictor Ltd DiaSorin SpA Elabscience Biotechnology Inc Bio-Techne Corp
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving factors for the ELISA diagnostic test market across the globe?

Key factors that such as rising infectious diseases among animals and increasing incidence of human infections are expected to boost the market growth for the ELISA diagnostic test market over the years.

What is ELISA diagnostic test?

Enzyme-Linked Immunosorbent Assay (ELISA) is a diagnostic technique that helps detect antibodies or infectious agents present in a biological fluid. Antibodies are produced by the body in response to an infection, and hence, an antibody ELISA test can help determine if an animal has come in contact with a specific virus. On the other hand, an antigen ELISA test can directly detect the virus in an infected animal.

What is the market CAGR value of ELISA diagnostic test market during forecast period?

The CAGR value of the surgical navigation system market during the forecasted period of 2020-2030 is 7.37%.

How is ELISA diagnostic test market segmented?

The ELISA diagnostic test market is segmented into adoption, test type, application and end user. Based on adoption the ELISA diagnostic test market is segmented in human and veterinary. Based on test type ELISA diagnostic test market is segmented into sandwich ELISA, indirect ELISA, competitive ELISA, and multiple and portable ELISA. Based on application the market is segmented into auto-immune disease, infectious disease, cancer diagnosis, protein quantification, and others. Based on end user is segmented into hospitals& diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospitals & diagnostic laboratories and others.

Which region is expected to witness significant demand for ELISA diagnostic test market in the coming years?

Global ELISA diagnostic test market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. North America held the largest market share of the ELISA diagnostic test market in 2022. With several North American market players focusing on research and development activities in serological diagnostic testing, the regional market for ELISA diagnostic test market is likely to propel in North America region during the forecast period.

Which application held the largest share in the ELISA diagnostic test market?

The infectious disease segment held the largest share of the market and dominated the global ELISA diagnostic test market in 2022.

Who are the key players in the ELISA diagnostic test market?

The ELISA diagnostic test market majorly consists of the players such Bio-Rad Laboratories Inc., Idexx Laboratories Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corp., Innovative Diagnostics SAS, Pictor Ltd., DiaSorin SpA, Elabscience Biotechnology Inc., Bio-Techne Corp. and others.

The List of Companies - ELISA Diagnostic Test Market

  1. Bio-Rad Laboratories Inc.
  2. Idexx Laboratories Inc.
  3. F. Hoffmann-La Roche Ltd.
  4. Thermo Fisher Scientific Inc.
  5. Abbott Laboratories
  6. Danaher Corp.
  7. Innovative Diagnostics SAS
  8. Pictor Ltd.
  9. DiaSorin SpA
  10. Elabscience Biotechnology Inc.
  11. Bio-Techne Corp.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports